Amplia Therapeutics Limited (ASX:ATX)

Amplia Therapeutics Revenue

Amplia Therapeutics had revenue of 2.63M AUD in the half year ending September 30, 2025, with 7.44% growth. This brings the company's revenue in the last twelve months to 5.01M, up 46.79% year-over-year. In the fiscal year ending March 31, 2025, Amplia Therapeutics had annual revenue of 3.78M, down -15.03%.

• Revenue (ttm): 5.01M
• Revenue Growth: +46.79%
• P/S Ratio: 13.32
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 66.70M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	3.78M	-669.04K	-15.03%
Mar 31, 2024	4.45M	3.26M	274.34%
Mar 31, 2023	1.19M	-793.83K	-40.03%
Mar 31, 2022	1.98M	449.80K	29.33%
Mar 31, 2021	1.53M	1.50M	4,380.44%